Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Baudin, E; Hayes, AR; Scoazec, JY; Filosso, PL; Lim, E; Kaltsas, G; Frilling, A; Chen, J; Kos-Kudła, B; Gorbunova, V; Wiedenmann, B; Nieveen, van, Dijkum, E; Ćwikła, JB; Falkerby, J; Valle, JW; Kulke, MH; Caplin, ME, , ENETS 2016 Munich Advisory Board Participants;ENETS, 2016, Munich, Advisory, Board, Participants.
Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms.
Neuroendocrinology. 2019; 108(1): 7-17.
Doi: 10.1159/000493980
Web of Science
PubMed
FullText
FullText_MUG
- Study Group Mitglieder der Med Uni Graz:
-
Krejs Günter Josef
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Pulmonary carcinoids (PCs) display the common features of all well-differentiated neuroendocrine neoplasms (NEN) and are classified as low- and intermediate-grade malignant tumours (i.e., typical and atypical carcinoid, respectively). There is a paucity of randomised studies dedicated to advanced PCs and management principles are drawn from the larger gastroenteropancreatic NEN experience. There is growing evidence that NEN anatomic subgroups have different biology and different responses to treatment and, therefore, should be investigated as separate entities in clinical trials. In this review, we discuss the existing evidence and limitations of tumour classification, diagnostics and staging, prognostication, and treatment in the setting of PC, with focus on unmet medical needs and directions for the future.
- Find related publications in this database (using NLM MeSH Indexing)
-
Biomedical Research - trends
-
Carcinoid Tumor - classification, diagnosis, drug therapy
-
Humans - administration & dosage
-
Lung Neoplasms - classification, diagnosis, drug therapy
-
Neuroendocrine Tumors - classification, diagnosis, drug therapy
-
Prognosis - administration & dosage
- Find related publications in this database (Keywords)
-
Pulmonary carcinoids
-
Bronchial carcinoid tumours
-
Neuroendocrine neoplasms
-
NET